Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

The changing face of pharma in the precision era

September 6, 2019 | Pharma, healthcare, personalised medicine, precision medicine 

Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.

The changing face of pharma in the precision era

NATASHA COWAN|6TH SEPTEMBER 2019

- PMLiVE

Nancy Brandt is not your typical medical information specialist. While medical affairs teams are usually focused on developing scientific communications about a product or service for healthcare professionals, she has been tasked with preparing a top 20 biopharma company for the future of precision medicine.

For pharma, it’s clear the future lies in making the right partnerships. Precision medicine equates understanding the patient’s molecular makeup and using this information and other clinical data to find targeted treatments. However, right now the policies and regulations are still being written. New stakeholders are entering the fray and bringing with them novel technologies that can improve patient outcomes.

We are on the brink of a new way of practising medicine and pharmaceutical companies have the opportunity to shape this future, but this hinges on collaborating with the right people and listening to what the complex network of stakeholders are asking of them.

This means moving away from a product-specific way of thinking to develop a deep insight into how society is changing as precision medicines emerge. As a result, Nancy is immersed in understanding the patient journey and developing agile ways of working to ensure the organisation stays one step ahead of novel developments. Armed with this information, she can then develop partnerships that will fuel innovative communications for the 21st-century patient and the complex stakeholder network, from doctors to policymakers.

Here, she reveals how she is embracing this new way of working and the lessons she has learned along the way.

DOWNLOAD THE ARTICLE HERE

This content was provided by Blue Latitude Health